Carotid artery stenting for primary and secondary stroke prevention

Adnan H Siddiqui1, Sabareesh K Natarajan, L Nelson Hopkins

  • 1Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA. asiddiqui@ubns.com

World Neurosurgery
|December 21, 2011
PubMed

Insights

Carotid artery stenting (CAS) is now a safe and effective alternative to carotid endarterectomy (CEA) for preventing strokes. The choice between CAS and CEA depends on individual patient needs.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Interventional Cardiology

Background:

  • Carotid artery disease is a significant cause of stroke-related disability and mortality.
  • Ischemic stroke is a leading cause of adult disability and mortality.
  • Carotid revascularization is a primary surgical intervention for stroke prevention.

Purpose of the Study:

  • To review the evidence for carotid revascularization.
  • To summarize current practices in managing carotid artery disease.
  • To evaluate the role of carotid artery stenting (CAS) versus carotid endarterectomy (CEA).

Main Methods:

  • Literature review of carotid revascularization evidence.
  • Analysis of randomized trials comparing CAS and CEA.
  • Emphasis on the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) results.

Main Results:

  • Early trials established carotid endarterectomy (CEA).
  • The CREST trial demonstrated CAS as a safe, effective, and durable alternative to CEA.
  • Technical advancements in CAS have occurred post-CREST.

Conclusions:

  • Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are complementary procedures.
  • Patient-specific factors guide the selection between CAS and CEA.
  • Judicious procedural choice ensures optimal patient outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...